48,584
edits
Difference between revisions of "Endometrial carcinoma"
Jump to navigation
Jump to search
→IHC
(→IHC) |
|||
| Line 220: | Line 220: | ||
High-grade endometrioid carcinoma versus serous carcinoma:<ref name=pmid15577675>{{Cite journal | last1 = Darvishian | first1 = F. | last2 = Hummer | first2 = AJ. | last3 = Thaler | first3 = HT. | last4 = Bhargava | first4 = R. | last5 = Linkov | first5 = I. | last6 = Asher | first6 = M. | last7 = Soslow | first7 = RA. | title = Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases. | journal = Am J Surg Pathol | volume = 28 | issue = 12 | pages = 1568-78 | month = Dec | year = 2004 | doi = | PMID = 15577675 }}</ref> | High-grade endometrioid carcinoma versus serous carcinoma:<ref name=pmid15577675>{{Cite journal | last1 = Darvishian | first1 = F. | last2 = Hummer | first2 = AJ. | last3 = Thaler | first3 = HT. | last4 = Bhargava | first4 = R. | last5 = Linkov | first5 = I. | last6 = Asher | first6 = M. | last7 = Soslow | first7 = RA. | title = Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases. | journal = Am J Surg Pathol | volume = 28 | issue = 12 | pages = 1568-78 | month = Dec | year = 2004 | doi = | PMID = 15577675 }}</ref> | ||
*p53 -ve, PR +ve, PTEN loss -- suggest endometrioid. | *p53 -ve, PR +ve, PTEN loss -- suggest endometrioid. | ||
*p16 and PTEN superior to ER, PR, and p53.<ref name=pmid20567148>{{Cite journal | last1 = Alkushi | first1 = A. | last2 = Köbel | first2 = M. | last3 = Kalloger | first3 = SE. | last4 = Gilks | first4 = CB. | title = High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes. | journal = Int J Gynecol Pathol | volume = 29 | issue = 4 | pages = 343-50 | month = Jul | year = 2010 | doi = 10.1097/PGP.0b013e3181cd6552 | PMID = 20567148 }}</ref> | |||
Notes: | Notes: | ||